Unveiled at Endo 2023, Osteoboost is heralded as the next big thing in the realm of bone health. Developed by Bone Health Technologies, Osteoboost is engineered to counter the loss of bone density and strength among postmenopausal women.
In a double-blinded study involving 126 women, Osteoboost achieved a staggering 82% reduction in bone strength loss and an 85% reduction in bone density loss through its targeted vibration technology.
Principal investigator Laura Bilek, Ph.D., declared Osteoboost to be a game-changer in combating post-menopausal bone loss. Laura Yecies, CEO of Bone Health Technologies, added that the device is a boon for the 53 million Americans grappling with osteopenia.
Osteoboost, with its cutting-edge technology and ease of use, is ready to usher in an unprecedented era in the treatment of bone health diseases.